CAE Inc. (NYSE:CAE) Q2 2025 Earnings Conference Call November 13, 2024 8:00 AM ET Company Participants: Andrew Arnovitz – Senior Vice President, Investor Relations and Enterprise Risk Management Marc Parent – President and Chief Executive Officer Constantino Malatesta – Interim Chief Financial Officer Nick Leontidis – Chief Operating Officer Conference Call Participants: Kevin Chiang –…
Kuehn Law Investigates Potential Breach of Fiduciary Duties by QuidelOrtho Corporation Officers and Directors New York, Nov. 13, 2024 /PRNewswire/ — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of QuidelOrtho Corporation (NASDAQ: QDEL) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, QuidelOrtho insiders…
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Acadia Healthcare Company, Inc. Los Angeles, CA / ACCESSWIRE / November 13, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. (“Acadia” or “the Company”) (NASDAQ:ACHC) for violations of 10(b)…
XRP News Sparks Fresh Interest in Crypto Wallets OKX Wallet Steps Up with Fractal Bitcoin Features The demand for crypto wallets intensifies as potential regulatory shifts under Trump’s administration bring new hope for approval of ETFs. As XRP news about ETFs sparks fresh interest due to potential regulatory shifts under Trump’s administration, the demand for…
NioCorp Announces Successful Private Placement with Gross Proceeds of $35 Million Subscribers in the Private Placement Include Certain NioCorp Officers and Directors for Gross Proceeds of Approximately $0.42 Million On November 13, 2024, NioCorp Developments Ltd. (“NioCorp” or the “Company”) (Nasdaq:NB) announced the successful completion of a non-brokered private placement, raising a total of $35…
The Growing Uranium Ore Market: A Promising Future Ahead Overview of Uranium Ore Market Growth The uranium ore market is set to experience significant growth in the coming years, according to a report from the Business Research Company. The market size is projected to increase from $1.11 billion in 2023 to $1.21 billion in 2024,…
Johnson & Johnson’s Oncology Franchise Flourishes in 2024 Darzalex Sales Soar in Third Quarter In the second half of 2024, Johnson & Johnson made significant progress in developing its oncology franchise. One of the standout achievements was the impressive growth in sales of Darzalex, a key drug in the company’s portfolio. In the third quarter…
Results from Adaptimmune Therapeutics’ IGNYTE-ESO Trial Introduction Adaptimmune Therapeutics plc (NASDAQ: ADAP) recently released data from the primary analysis of its pivotal Phase 2 IGNYTE-ESO trial of lete-cel. The trial focused on individuals with synovial sarcoma or myxoid/round cell liposarcoma (MRCLS) who had previously undergone anthracycline-based therapy. Key Findings The results of the study showed…
